| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Bruker Daltonics, Inc. |
| 15 Fortune Drive, Billerica, MA 01821 * (978) 663-3660 |
| Business Description | The company is a leading developer and provider of innovative life science tools based on mass spectrometry. |
| Offering Information Company has | |||
| Trading As | BDAL (NASNTL) | Industry | Manufacturing (SIC 3826) |
| Type of Stock Offered | Common Shares | Filing Date | 4/14/00 |
| Domestic Shares Offered | 8,000,000 | Offer Date | 8/3/00 |
| Foreign Shares Offered | 0 | Filing Range | $12.00 - $13.00 |
| Company Shares | 8,000,000 | Offer Price | $13.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.910 |
| Gross Proceeds | $104,000,000 | Selling | $0.540 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 53,500,000 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| UBS Warburg LLC | Lead Manager | |
| CIBC World Markets | Co-manager | (212) 667-7400 |
| Thomas Weisel Partners LLC | Co-manager | (415) 364-2500 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/95 | 12/31/96 | 12/31/97 | 12/31/98 | 12/31/99 | ||
| Revenues | 32.125 | 46.072 | 51.125 | 42.207 | 64.690 | - | - |
| Income from Oper. | 1.681 | 7.190 | 2.598 | -0.161 | 2.640 | - | - |
| Net Income | 0.899 | 4.263 | 0.564 | -0.505 | 1.249 | - | - |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | 43.41 | 10.97 | -17.44 | 53.268 | - | ||
| Net Income Growth (%) | 374.19 | -86.77 | - | - | - | ||
| Oper. Profit Margin (%) | 5.23 | 15.61 | 5.08 | - | 4.08 | - | - |
| Net Profit Margin (%) | 2.80 | 9.25 | 1.10 | - | 1.93 | - | - |
| Cash Flow - Oper. | 4.94 | - | - | ||||
| Cash Flow - Inv. | -4.44 | - | - | ||||
| Cash Flow - Fin. | 0.36 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/99 | Financial Ratios | ||||
| Total Assets | 67.31 | Current Assets | 41.52 | Current Ratio | 1.41 |
| Total Liab. | 57.25 | Current Liab. | 29.44 | Debt Ratio | 85.06% |
| Total Equity | 10.06 | Working Cap. | 12.08 | Debt to Equity Ratio | 5.69 |
| Cash | 2.44 | Return on Assets | 1.86% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes including research and development, expansion of sales and marketing capabilities, and working capital, funding potential strategic acquisitions, and repayment of outstanding bank debt. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Hutchins Wheeler & Dittmar |
| Bank's Law Firm | Ropes & Gray |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |